119 related articles for article (PubMed ID: 35552780)
1. Right ventricular failure is strongly associated with mortality in patients with moderate-to-severe COVID-19-related ARDS and appears related to respiratory worsening.
Evrard B; Goudelin M; Giraudeau B; François B; Vignon P
Intensive Care Med; 2022 Jun; 48(6):765-767. PubMed ID: 35552780
[No Abstract] [Full Text] [Related]
2. Persistent Right Ventricle Dilatation in SARS-CoV-2-Related Acute Respiratory Distress Syndrome on Extracorporeal Membrane Oxygenation Support.
Lazzeri C; Bonizzoli M; Batacchi S; Cianchi G; Franci N; Socci F; Peris A
J Cardiothorac Vasc Anesth; 2022 Jul; 36(7):1956-1961. PubMed ID: 34538743
[TBL] [Abstract][Full Text] [Related]
3. Likelihood of amyloid formation in COVID-19-induced ARDS.
Sinha N; Thakur AK
Trends Microbiol; 2021 Nov; 29(11):967-969. PubMed ID: 33795156
[TBL] [Abstract][Full Text] [Related]
4. Transpulmonary pressure measurements and lung mechanics in patients with early ARDS and SARS-CoV-2.
Baedorf Kassis E; Schaefer MS; Maley JH; Hoenig B; Loo Y; Hayes MM; Moskowitz A; Talmor D
J Crit Care; 2021 Jun; 63():106-112. PubMed ID: 33676795
[TBL] [Abstract][Full Text] [Related]
5. Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience.
Mahida RY; Chotalia M; Alderman J; Patel C; Hayden A; Desai R; Beesley E; Crowley LE; Soltan M; Bangash M; Parekh D; Patel J; Thickett DR
BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33257441
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal Membrane Oxygenation with Right Ventricular Assist Device for COVID-19 ARDS.
Cain MT; Smith NJ; Barash M; Simpson P; Durham LA; Makker H; Roberts C; Falcucci O; Wang D; Walker R; Ahmed G; Brown SA; Nanchal RS; Joyce DL
J Surg Res; 2021 Aug; 264():81-89. PubMed ID: 33789179
[TBL] [Abstract][Full Text] [Related]
8. A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.
Park E; You J
J Korean Med Sci; 2022 Mar; 37(10):e82. PubMed ID: 35289141
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
Galassi G; Marchioni A
Acta Neurol Belg; 2021 Jun; 121(3):633-642. PubMed ID: 33811309
[TBL] [Abstract][Full Text] [Related]
10. Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.
Kosanovic D; Yaroshetskiy AI; Tsareva NA; Merzhoeva ZM; Trushenko NV; Nekludova GV; Schermuly RT; Avdeev SN
Int J Infect Dis; 2021 Mar; 104():108-110. PubMed ID: 33352323
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
Reizine F; Lesouhaitier M; Gregoire M; Pinceaux K; Gacouin A; Maamar A; Painvin B; Camus C; Le Tulzo Y; Tattevin P; Revest M; Le Bot A; Ballerie A; Cador-Rousseau B; Lederlin M; Lebouvier T; Launey Y; Latour M; Verdy C; Rossille D; Le Gallou S; Dulong J; Moreau C; Bendavid C; Roussel M; Cogne M; Tarte K; Tadié JM
J Clin Immunol; 2021 Apr; 41(3):515-525. PubMed ID: 33387156
[TBL] [Abstract][Full Text] [Related]
12. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of pediatric patients with acute respiratory distress syndrome due to COVID-19.
Marroquín-Yáñez ML; Medeiros M; Chávez-López A; Carrillo-López HA; Soto-Bautista NP; Jarillo-Quijada AE; Gómez-Murillo SY; Láscari-Jiménez EC; Ruiz-Quiñones G; Barrera-Alonzo CJ; Contras-Santiago EM; Hernández-Hernández M
Bol Med Hosp Infant Mex; 2022; 79(3):170-179. PubMed ID: 35882022
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Outcomes of Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study.
Wang F; Ran L; Qian C; Hua J; Luo Z; Ding M; Zhang X; Guo W; Gao S; Gao W; Li C; Liu Z; Li Q; Ronco C
Blood Purif; 2021; 50(4-5):499-505. PubMed ID: 33291098
[TBL] [Abstract][Full Text] [Related]
15. Low hemodynamic impact of moderate ARDS caused by SARS-CoV2.
Ioan AM; Gonzalez-Lorenzo O; Kallmeyer Mayor A; Pérez-Calvo C; Santos A
Med Intensiva (Engl Ed); 2023 Jun; 47(6):348-350. PubMed ID: 36931994
[No Abstract] [Full Text] [Related]
16. Acute Respiratory Distress Syndrome: Diagnosis and Management.
Saguil A; Fargo MV
Am Fam Physician; 2020 Jun; 101(12):730-738. PubMed ID: 32538594
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and risk factors associated with acute respiratory distress syndrome in pregnant women diagnosed with COVID-19: a multi-center case-control study.
Kazemi Aski S; Norooznezhad AH; Shamshirsaz AA; Mostafaei S; Aleyasin A; Nabavian SM; Alimohammadi S; Ahangari R; Ariana S; Ghotbizadeh F; Tara F; Pooransari P; Gharib Laki M; Zarean E; Soleimani Z; Saliminia A; Havaei A; Akbari R; Ramezani M; Soleimani A; Naemi M; Shamshirsaz AA; Hantoushzadeh S
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):4884-4888. PubMed ID: 33550858
[TBL] [Abstract][Full Text] [Related]
18. Prolonged Intermittent Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome.
Ramirez-Sandoval JC; Gaytan-Arocha JE; Xolalpa-Chávez P; Mejia-Vilet JM; Arvizu-Hernandez M; Rivero-Sigarroa E; Torruco-Sotelo C; Correa-Rotter R; Vega-Vega O
Blood Purif; 2021; 50(3):355-363. PubMed ID: 33105136
[TBL] [Abstract][Full Text] [Related]
19. Validation of the P/FPE index in a cohort of patients with ARDS due to SARS-CoV-2.
González-Castro A; Martos Benítez FD; Fernandez-Rodriguez A; Orama-Requejo V; Ferrero-Franco R; Peñasco Y
Med Intensiva (Engl Ed); 2023 Jul; 47(7):413-415. PubMed ID: 37179208
[No Abstract] [Full Text] [Related]
20. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2.
Zheng J; Miao J; Guo R; Guo J; Fan Z; Kong X; Gao R; Yang L
Front Cell Infect Microbiol; 2022; 12():931061. PubMed ID: 35774402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
